University of Texas's MD Anderson Research Highlights for Aug. 10
August 11, 2022
August 11, 2022
HOUSTON, Texas, Aug. 11 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Featuring CRISPR screens to enhance chemotherapy benefits, targeted therapies for kidney and colorectal cancer, and a novel engineered TIL therapy for ovarian cancer
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical . . .
* * *
Featuring CRISPR screens to enhance chemotherapy benefits, targeted therapies for kidney and colorectal cancer, and a novel engineered TIL therapy for ovarian cancer
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical . . .